<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.9'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//pharminent.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://pharminent.com/merck-wins-first-fda-approval-of-an-oral-pcsk9-inhibitor-with-cholesterol-pill-lipfendra/</loc>
  <lastmod>2026-07-16T23:42:59Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra</news:title>
   <news:publication_date>2026-07-16T20:22:35Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/strategic-news-watch/strategic-news-watch-july-16-2026/</loc>
  <lastmod>2026-07-16T15:49:46Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Strategic News Watch • July 16, 2026</news:title>
   <news:publication_date>2026-07-16T15:49:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/fda-approves-at-home-leqembi-for-early-alzheimers-disease/</loc>
  <lastmod>2026-07-16T20:36:04Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>FDA Approves At-Home Leqembi for Early Alzheimer&amp;#039;s Disease</news:title>
   <news:publication_date>2026-07-16T14:37:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/lilly-enters-psychedelic-realm-through-2-8bn-ataibeckley-takeover/</loc>
  <lastmod>2026-07-17T14:34:14Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover</news:title>
   <news:publication_date>2026-07-16T13:34:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-july-8-2026/</loc>
  <lastmod>2026-07-16T12:14:30Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • July 8, 2026</news:title>
   <news:publication_date>2026-07-16T12:14:28Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-july-15-2026/</loc>
  <lastmod>2026-07-15T22:17:32Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • July 15, 2026</news:title>
   <news:publication_date>2026-07-15T22:17:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/strategic-news-watch-july-15-2026/</loc>
  <lastmod>2026-07-15T20:29:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>J&amp;amp;J Beats Q2 Estimates, Raises Full-Year Guidance on Innovative Medicine Strength</news:title>
   <news:publication_date>2026-07-15T20:29:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/jj-streamlines-pharma-supply-chain-amid-55b-us-manufacturing-push/</loc>
  <lastmod>2026-07-15T20:29:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>J&amp;amp;J Streamlines Pharma Supply Chain Amid $55B US Manufacturing Push</news:title>
   <news:publication_date>2026-07-15T20:29:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-july-15-2026/</loc>
  <lastmod>2026-07-15T20:05:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Manufacturing Intelligence • Weekly Digest • July 15, 2026</news:title>
   <news:publication_date>2026-07-15T20:05:35Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/strategic-news-watch/strategic-news-watch-july-15-2026/</loc>
  <lastmod>2026-07-15T16:03:50Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Strategic News Watch • July 15, 2026</news:title>
   <news:publication_date>2026-07-15T16:03:48Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/aaic-2026-lilly-keeps-door-open-for-maintenance-kisunla-after-amyloid-clearance/</loc>
  <lastmod>2026-07-17T14:41:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AAIC 2026: Lilly keeps door open for maintenance Kisunla after amyloid clearance</news:title>
   <news:publication_date>2026-07-15T12:51:11Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/celcuity-gets-fda-nod-for-first-in-class-breast-cancer-drug/</loc>
  <lastmod>2026-07-16T13:05:35Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Celcuity gets FDA nod for first-in-class breast cancer drug</news:title>
   <news:publication_date>2026-07-15T09:15:02Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
